[1]Patent:US2001/49445,2001,A1
[1]CurrentPatentAssignee:JLLPARTNERSINC-WO2006/108493,2006,A1Locationinpatent:Page/Pagecolumn6
107367-98-6
103788-65-4
22086-89-1
258346-49-5
1017231-27-4
1017369-15-1
110623-73-9 | Epimedin b | AA008RXX | MFCD04039834
1050505-83-3 | 4-(2-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)morpholine | AA008S4D | MFCD03412096
1075719-87-7 | 2-(4-ethylphenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane | AA008SDG | MFCD18643353
104145-95-1 | Cefditoren | AA008SKY | MFCD00865118
1124175-25-2 | Methyl (1r,3r)-3-hydroxycyclopentanecarboxylate | AA008SQO | MFCD28962589
105078-92-0 | 17ALPHA-HYDROXYPREGNENOLONE-21,21,21-D3 | AA008SX0 | MFCD01317456
104579-03-5 | 5'-O-(4,4'-Dimethoxytrityl)-N4-benzoyl-5-methyl-2'-deoxycytidine | AA008T57 | MFCD00057965
1206101-20-3 | GLPG0634 analog | AA008TDP | MFCD26406012
1123231-07-1 | WAY-262611 | AA008THU | MFCD20527803
1018673-42-1 | cyclopentyl 2-cyclohexyl-2-((6-(3-(hydroxyamino)-3-oxopropyl)pyridin-3-yl)methylamino)acetate | AA008TM8 | MFCD29924725